Biomarker-Driven Therapy for NSCLC: Experts Discuss Current and Future Trends

Gain expert guidance on optimal use of biomarkers to guide treatment decisions for advanced NSCLC with this educational program featuring an on-demand webcast and downloadable slidesets from a live CCO webinar along with a podcast of the experts answering questions from the audience.

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Amgen, Inc.

Lilly

Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme